Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1994 2
1995 2
1996 3
1997 2
1998 3
1999 4
2000 2
2001 8
2002 5
2003 6
2004 6
2005 9
2006 7
2007 5
2008 12
2009 11
2010 11
2011 10
2012 8
2013 9
2014 7
2015 7
2016 18
2017 7
2018 11
2019 15
2020 13
2021 7
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

199 results
Results by year
Filters applied: . Clear all
Page 1
Polypharmacology of dopamine receptor ligands.
Butini S, Nikolic K, Kassel S, Brückmann H, Filipic S, Agbaba D, Gemma S, Brogi S, Brindisi M, Campiani G, Stark H. Butini S, et al. Among authors: campiani g. Prog Neurobiol. 2016 Jul;142:68-103. doi: 10.1016/j.pneurobio.2016.03.011. Epub 2016 May 24. Prog Neurobiol. 2016. PMID: 27234980 Review.
Cinnamides Target Leishmania amazonensis Arginase Selectively.
da Silva ER, Come JAADSS, Brogi S, Calderone V, Chemi G, Campiani G, Oliveira TMFS, Pham TN, Pudlo M, Girard C, Maquiaveli CDC. da Silva ER, et al. Among authors: campiani g. Molecules. 2020 Nov 12;25(22):5271. doi: 10.3390/molecules25225271. Molecules. 2020. PMID: 33198198 Free PMC article.
Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials.
Relitti N, Saraswati AP, Federico S, Khan T, Brindisi M, Zisterer D, Brogi S, Gemma S, Butini S, Campiani G. Relitti N, et al. Among authors: campiani g. Curr Top Med Chem. 2020;20(6):433-457. doi: 10.2174/1568026620666200102104930. Curr Top Med Chem. 2020. PMID: 31894749 Review.
HCV-targeted antivirals: current status and future challenges.
Gemma S, Brogi S, Novellino E, Campiani G, Maga G, Brindisi M, Butini S. Gemma S, et al. Among authors: campiani g. Curr Pharm Des. 2014;20(21):3445-64. doi: 10.2174/13816128113199990630. Curr Pharm Des. 2014. PMID: 24001232 Review.
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents.
Grillo A, Fezza F, Chemi G, Colangeli R, Brogi S, Fazio D, Federico S, Papa A, Relitti N, Di Maio R, Giorgi G, Lamponi S, Valoti M, Gorelli B, Saponara S, Benedusi M, Pecorelli A, Minetti P, Valacchi G, Butini S, Campiani G, Gemma S, Maccarrone M, Di Giovanni G. Grillo A, et al. Among authors: campiani g. ACS Chem Neurosci. 2021 May 5;12(9):1716-1736. doi: 10.1021/acschemneuro.1c00192. Epub 2021 Apr 23. ACS Chem Neurosci. 2021. PMID: 33890763
Effects of drug resistance mutations L100I and V106A on the binding of pyrrolobenzoxazepinone nonnucleoside inhibitors to the human immunodeficiency virus type 1 reverse transcriptase catalytic complex.
Locatelli GA, Campiani G, Cancio R, Morelli E, Ramunno A, Gemma S, Hübscher U, Spadari S, Maga G. Locatelli GA, et al. Among authors: campiani g. Antimicrob Agents Chemother. 2004 May;48(5):1570-80. doi: 10.1128/AAC.48.5.1570-1580.2004. Antimicrob Agents Chemother. 2004. PMID: 15105107 Free PMC article.
Malaria chemotherapy: recent advances in drug development.
Gemma S, Travagli V, Savini L, Novellino E, Campiani G, Butini S. Gemma S, et al. Among authors: campiani g. Recent Pat Antiinfect Drug Discov. 2010 Nov;5(3):195-225. doi: 10.2174/157489110793348776. Recent Pat Antiinfect Drug Discov. 2010. PMID: 20738242 Review.
199 results